Literature DB >> 9087987

A case of tetrabenazine-induced neuroleptic malignant syndrome after prolonged treatment.

G M Petzinger1, S B Bressman.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1997        PMID： 9087987     DOI： 10.1002/mds.870120219

Source DB:  PubMed          Journal:  Mov Disord        ISSN： 0885-3185            Impact factor:   10.338


× No keyword cloud information.
  5 in total

1.  Severe hyperthermia during tetrabenazine therapy for tardive dyskinesia.

Authors:  E Stevens; A Roman; M Houa; D Razavi; N Jaspar
Journal:  Intensive Care Med       Date:  1998-04       Impact factor: 17.440

Review 2.  The management of tics.

Authors:  David Shprecher; Roger Kurlan
Journal:  Mov Disord       Date:  2009-01-15       Impact factor: 10.338

Review 3.  Tourette's syndrome and role of tetrabenazine: review and personal experience.

Authors:  Mauro Porta; Marco Sassi; Mario Cavallazzi; Maurizio Fornari; Arianna Brambilla; Domenico Servello
Journal:  Clin Drug Investig       Date:  2008       Impact factor: 2.859

4.  Neuroleptic malignant syndrome: a review for neurohospitalists.

Authors:  Brian D Berman
Journal:  Neurohospitalist       Date:  2011-01

5.  Risk of Neuroleptic Malignant Syndrome with Vesicular Monoamine Transporter Inhibitors.

Authors:  Stanley N Caroff
Journal:  Clin Psychopharmacol Neurosci       Date:  2020-05-31       Impact factor: 2.582
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.